5-HT(2C) receptor binding is increased in the substantia Nigra pars reticulata in Parkinson's disease

Movement Disorders

Volumn 15, Issue 6, 2000, Pages 1064-1069

  Fox, Susan H ^a   Brotchie, Jonathan M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

5 HT(2C) receptor; Autoradiography; Parkinson's disease

Indexed keywords

1 (1 METHYL 5 INDOLYL) 3 (3 PYRIDYL)UREA; MESULERGINE; SEROTONIN 2C RECEPTOR; ANTIPARKINSON AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; ERGOLINE DERIVATIVE; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ADULT; ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; BINDING AFFINITY; BINDING SITE; CAUDATE NUCLEUS; CONTROLLED STUDY; FEMALE; GLOBUS PALLIDUS; HUMAN; HUMAN TISSUE; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; RECEPTOR BINDING; RECEPTOR SENSITIVITY; SUBSTANTIA NIGRA; TISSUE SECTION; AGED; BRAIN; COMPARATIVE STUDY; DRUG EFFECT; DYSKINESIA; METABOLISM;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; AUTORADIOGRAPHY; BINDING SITES; BRAIN; DOPAMINE AGONISTS; DYSKINESIA, DRUG-INDUCED; ERGOLINES; FEMALE; HUMANS; MALE; PARKINSON DISEASE; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SUBSTANTIA NIGRA;

EID: 0033625998     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8257(200011)15:6<1064::AID-MDS1002>3.0.CO;2-C     Document Type: Article

References (37)

1. Problems with current pharmacological treatment of Parkinson's disease
2. Novel approaches to the symptomatic treatment of parkinsonian syndromes: Alternatives and adjuncts to dopamine-replacement
3. The functional anatomy of basal ganglia disorders
4. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
5. Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate
6. An hypothesis on the pathophysiological mechanisms that underline levodopa-or dopamine agonist-induced dyskinesia in Parkinson's disease: Implications for future strategies in treatment
7. The nucleus raphe dorsalis of the rat and its projection upon the caudate putamen. A combined cytoarchitectonic, immunohistochemical and retrograde transport study
8. Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey
9. Serotonin and dopamine metabolites in brain regions and cerebrospinal fluid of a primate species: Effects of ketamine and fluphenazine
10. Immunohisto-chemical demonstration of serotonin nerve fibres in the corpus striatum of the rat, cat and monkey
11. Monoamine transmitters and their metabolites in the basal ganglia of Huntington's disease and control post-mortem brain
12. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I: Serotonin-1 receptors
13. Serotonin receptors in the human brain-III. Autoradiographic mapping of serotonin-1 receptors
14. 5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system
15. Distribution of serotonin 5-HT1C receptor mRNA in adult rat brain
16. Localization of the mRNA for the 5-HT2 receptor by in situ hybridization histochemistry. Correlation with the distribution of receptor sites
17. Distribution of the serotonin 5-HT2 receptor family mRNAs: Comparison between 5-HT2A and 5-HT2C receptors
18. Comparative localization of serotonin 1A, 1C, and 2 receptor subtype mRNAs in rat brain
19. Excitation of rat substantia nigra pars reticulata neurons by 5-hydroxytryptamine in vitro: Evidence for a direct action mediated by 5-hydroxytryptamine2C receptors
20. N-(1-methyl-5-indoyl)-N'-(3-pyridyl) urea hydrochloride: The first selective 5-HT(1C) receptor antagonist
21. 125I-lysergic acid diethylamide binds to a novel serotonergic site on rat choroid plexus epithelial cells
22. The concept of selectivity in 5-HT receptor research
23. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases
24. The binding of serotonergic ligands to the porcine choroid plexus: Characterization of a new type of serotonin recognition site
25. Serotonin receptors in the human brain. II. Characterisation and autoradiographic localisation of 5-HT1C and 5-HT2 recognition sites
26. 3H]Mesulergine, a selective ligand for serotonin-2 receptors
27. 3H-ketanserin binding to the cloned 5-HT(2A) receptor
28. Evidence for expression of the 5-HT(2B) receptor mRNA in rat brain
29. Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor
30. Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system
31. 5-Hydroxytryptamine (5-HT4) receptors in post mortem human brain tissue: Distribution, pharmacology and effects of neurodegenerative diseases
32. Serotonin-1 receptor binding sites in the human basal ganglia are decreased in Huntington's chorea but not in Parkinson's disease: A quantitative in vitro autoradiography study
33. Regulation of serotonin-2C receptor G-protein coupling by RNA editing
34. Behavioural effects of 5-HT(2C) receptor antagonism in the substantia nigra zona reticulata of the 6-hydroxydopamine lesioned rat model of Parkinson's disease
35. Normethylclozapine potentiates the action of quinpirole in the 6-hydroxydopamine lesioned rat
36. Levodopa-induced dyskinesias are improved by fluoxetine